Center for biologics evaluation and research (CBER) requirement for biologics effectiveness and safety (BEST) initiative #3: health care data sources for surveillance of biologics (BEST 3)
Ended Awarded Last action
- Contract number
- 75F40124F19001
- Awardee
-
The Lewin Group, Inc. UEI KRVRMDJKAA16 Part of Unitedhealth Group Incorporated
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $8,256,834
Award facts
- Contract value 100% obligated
- $8,256,834.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 518210 Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Multiple Award, Fair Opportunity
- Pricing
- Time and Materials
- Place of performance
- La Crosse, WI 54603, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $8,256,834 |
About this award
This is a $8,256,834.00 Delivery Order contract awarded by the Food and Drug Administration (FDA) to The Lewin Group, Inc., a subsidiary of UnitedHealth Group Incorporated. The contract supports the FDA's Center for Biologics Evaluation and Research (CBER) Biologics Effectiveness and Safety (BEST) Initiative #3, which focuses on health care data sources for surveillance of biologics. This is a Time and Materials contract with a performance period through September 29, 2025. The Lewin Group has several Indefinite Delivery/Indefinite Quantity (IDIQ) contracts with the FDA and other agencies within the Department of Health and Human Services that enable efficient access to their expertise in health policy research, data analytics, program evaluation, and implementation support.
Quick answers
Who was awarded contract 75F40124F19001?
75F40124F19001 was awarded to The Lewin Group, Inc. by Food and Drug Administration (Department of Health and Human Services) on September 27, 2024.
How much is contract 75F40124F19001 worth?
The government has obligated $8,256,834 on 75F40124F19001.
Is contract 75F40124F19001 an order under another contract?
Yes. 75F40124F19001 is a delivery order under 75F40124D00044, an indefinite delivery contract, on CBER BEST Initiative 3 - Data Sources for Surveillance of Biologics.
Was contract 75F40124F19001 competed?
The extent of competition for 75F40124F19001 was full and open competition. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award